| SEC Info ||Home||Search||My Interests||Help||Sign In||Please Sign In|
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/04/21 Omega Healthcare Investors Inc 8-K:8,9 3/03/21 12:303K Toppan Merrill/FA
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 31K 2: EX-99.1 Miscellaneous Exhibit HTML 15K 3: EX-99.2 Miscellaneous Exhibit HTML 22K 8: R1 Cover HTML 48K 10: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- tm218655d1_8k_htm XML 15K 9: EXCEL IDEA Workbook of Financial Reports XLSX 6K 5: EX-101.LAB XBRL Labels -- ohi-20210303_lab XML 97K 6: EX-101.PRE XBRL Presentations -- ohi-20210303_pre XML 64K 4: EX-101.SCH XBRL Schema -- ohi-20210303 XSD 13K 11: JSON XBRL Instance as JSON Data -- MetaLinks 25± 34K 12: ZIP XBRL Zipped Folder -- 0001104659-21-031756-xbrl Zip 21K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM i 8-K
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i March 3, 2021
i OMEGA HEALTHCARE INVESTORS, INC.
(Exact name of registrant as specified in its charter)
|i Maryland||i 1-11316||i 38-3041398|
|(State or other jurisdiction of incorporation)||(Commission File Number)||(IRS Employer Identification No.)|
i 303 International Circle
i Suite 200
i Hunt Valley, i Maryland i 21030
(Address of principal executive offices / Zip Code)
( i 410) i 427-1700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|i ¨||Written communications pursuant to Rule 425 under the Securities Act.|
|i ¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act.|
|i ¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.|
|i ¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.|
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
|i Common Stock, $.10 par value||i OHI||i New York Stock Exchange|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 8.01 Other Events.
On March 3, 2021, Omega Healthcare Investors, Inc., a Maryland corporation (“Omega”), issued a press release announcing the pricing of an underwritten public offering (the “Offering”) of $700,000,000 aggregate principal amount of 3.250% senior unsecured notes due 2033. The press release announcing the pricing of the Offering is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Also on March 3, 2021, Omega issued a press release announcing that it has amended its previously announced tender offer (the "Tender Offer") to purchase for cash its 4.375% Senior Notes due 2023 (the "Notes") by increasing the aggregate principal amount from $250,000,000 to $350,000,000. All other terms of the Tender Offer remain unchanged. The press release announcing the amendment to the Tender Offer is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are being filed herewith:
|99.1||Press Release related to Offering, dated March 3, 2021|
|99.2||Press Release related to Tender Offer, dated March 3, 2021|
|104||Cover Page Interactive Data File (embedded within the Inline XBRL document)|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|OMEGA HEALTHCARE INVESTORS, INC.|
|Dated: March 3, 2021||By:||/s/ Gail D. Makode|
|Gail D. Makode|
|Chief Legal Officer, General Counsel and Secretary|
|This ‘8-K’ Filing||Date||Other Filings|
|Filed as of:||3/4/21|
|Filed on / For Period end:||3/3/21||424B5, 8-K, FWP|
|List all Filings|